{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:26:35Z","timestamp":1793647595700,"version":"4.5.1"},"reference-count":27,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and\u00a0Objectives: Radiation therapy (RT) plays a crucial role in managing prostate cancer, offering effective disease control and improving survival rates in both localized and recurrent cases. However, RT can lead to hemorrhagic cystitis, a significant late complication resulting in chronic morbidity and other health issues. This study aims to evaluate the real-world incidence of radiation-induced hemorrhagic cystitis requiring surgical intervention. Materials and Methods: This retrospective cohort study analyzed data from prostate cancer survivors treated for hematuria at our center between January 2014 and January 2024. Patients were included if cystoscopy identified radiation cystitis as the cause of hematuria. Descriptive statistics were used, and binomial logistic regression analyses with univariate and multivariate analysis were performed to identify risk factors for worse outcomes. Results: Fifty-two patients met the inclusion criteria. The estimated cumulative incidence at a median follow-up of 5.3 years was 4.5%. Among the participants, 21.2% required more than two transurethral bladder fulguration (TUBF) procedures, and 38.5% needed more than two hospital admissions for hematuria management. The median time to the first fulguration was 64 months. Blood transfusions were necessary in 53.8% of cases, and 38.5% required hyperbaric oxygen therapy. Ultimately, 5.8% of the patients underwent cystectomy. Univariate analysis identified ischemic heart disease (IHD) and antiplatelet therapy as significant risk factors (OR: 5.17 and 5.18, respectively), along with longer time to first fulguration (OR: 5.02). Multivariate analysis confirmed antiplatelet therapy (OR: 2.8, p = 0.05) and time to first TUBF (OR: 1.8, p = 0.02) as significant predictors of multiple procedures. Conclusions: Radiation cystitis remains a significant burden on prostate cancer survivors. Patients on antithrombotic agents, those with delayed initial presentations, and those who received radiation as salvage therapy are more likely to experience higher morbidity.<\/jats:p>","DOI":"10.3390\/medicina60111746","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T05:47:33Z","timestamp":1729748853000},"page":"1746","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer Survivors: The Hidden Toll"],"prefix":"10.3390","volume":"60","author":[{"given":"Ren\u00e9","family":"Gatsinga","sequence":"first","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J. H.","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0040-0509","authenticated-orcid":false,"given":"Jacinda G. G.","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Center Singapore, Singapore 168583, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youquan","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Center Singapore, Singapore 168583, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L. C.","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Center Singapore, Singapore 168583, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence W. K.","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Center Singapore, Singapore 168583, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4353-8439","authenticated-orcid":false,"given":"Jeffrey K. L.","family":"Tuan","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, National Cancer Center Singapore, Singapore 168583, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Guang","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3844-7567","authenticated-orcid":false,"given":"Kenneth","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S. P.","family":"Yuen","sequence":"additional","affiliation":[{"name":"Department of Urology, Singapore General Hospital, Singapore 169608, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.21037\/tcr-20-2589","article-title":"Urological complications after radiation therapy\u2014Nothing ventured, nothing gained: A Narrative Review","volume":"10","author":"Krajewski","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.urology.2024.04.035","article-title":"Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis from a National Database","volume":"191","author":"Bologna","year":"2024","journal-title":"Urology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.prnil.2020.07.006","article-title":"Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: Factors associated to hospitalization and treatment strategies","volume":"9","author":"Sanguedolce","year":"2021","journal-title":"Prostate Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41391-022-00520-x","article-title":"Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: A systematic review and meta-analysis","volume":"26","author":"David","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.urology.2019.05.034","article-title":"Incidence and Morbidity of Radiation-Induced Hemorrhagic Cystitis in Prostate Cancer","volume":"131","author":"Martin","year":"2019","journal-title":"Urology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"346812","DOI":"10.1155\/2015\/346812","article-title":"A Narrative Review on the Pathophysiology and Management for Radiation Cystitis","volume":"2015","author":"Browne","year":"2015","journal-title":"Adv. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Helissey, C., Cavallero, S., Brossard, C., Dusaud, M., Chargari, C., and Fran\u00e7ois, S. (2021). Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives. Cells, 10.","DOI":"10.3390\/cells10010021"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/bju.14145","article-title":"Radiotherapy-related complications presenting to a urology department: A more common problem than previously thought?","volume":"121","author":"Ma","year":"2018","journal-title":"BJU Int."},{"key":"ref_12","unstructured":"(2024, August 19). Common Terminology Criteria for Adverse Events (CTCAE)|Protocol Development|CTEP, Available online: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00000478-197806000-00005","article-title":"Radiation injury in surgical pathology. Part I","volume":"2","author":"Fajardo","year":"1978","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s40265-015-0443-5","article-title":"A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis","volume":"75","author":"Liem","year":"2015","journal-title":"Drugs"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/COC.0000000000000016","article-title":"Hemorrhagic radiation cystitis","volume":"38","author":"Mendenhall","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000521723","article-title":"Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer","volume":"107","author":"Makino","year":"2023","journal-title":"Urol. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.eururo.2019.05.011","article-title":"Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy","volume":"76","author":"Akthar","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): A randomised, controlled, phase 2\u20133 trial","volume":"20","author":"Oscarsson","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yang, T.K., Wang, Y.J., Li, H.J., Yu, Y.F., Huang, K.W., and Cheng, J.C.H. (2024). Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic Cystitis: A Systematic Review and Meta-Analysis. J. Clin. Med., 13.","DOI":"10.3390\/jcm13164724"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.juro.2014.06.030","article-title":"Cystectomy for refractory hemorrhagic cystitis: Contemporary etiology, presentation and outcomes","volume":"192","author":"Linder","year":"2014","journal-title":"J. Urol."},{"key":"ref_21","first-page":"789.e1","article-title":"Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach","volume":"39","author":"Tachibana","year":"2021","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hall, W.A., Deshmukh, S., Bruner, D.W., Michalski, J.M., Purdy, J.A., Bosch, W., Bahary, J.-P., Patel, M.P., Parliament, M.B., and Lock, M.I. (2022). Quality of Life Implications of Dose Escalated External Beam Radiation, Results of a Prospective Randomized Phase III Clinical Trial, RTOG 0126. Int. J. Radiat. Oncol. Biol. Phys., 112.","DOI":"10.1016\/j.ijrobp.2021.07.004"},{"key":"ref_23","first-page":"81","article-title":"The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis","volume":"38","author":"Wang","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/1878-0261.12751","article-title":"Image guidance in radiation therapy for better cure of cancer","volume":"14","author":"Guckenberger","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-20-00031.1","article-title":"Consensus Statement on Proton Therapy for Prostate Cancer","volume":"8","author":"Bryant","year":"2021","journal-title":"Int. J. Part Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/pros.24525","article-title":"Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial","volume":"83","author":"Hasan","year":"2023","journal-title":"Prostate"},{"key":"ref_27","first-page":"100822","article-title":"Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center","volume":"48","author":"Sosa","year":"2024","journal-title":"Clin. Transl. Radiat. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1746\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:19:27Z","timestamp":1760113167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/11\/1746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["medicina60111746"],"URL":"https:\/\/doi.org\/10.3390\/medicina60111746","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]}}}